ASND logo

ASND
Ascendis Pharma

1,487
Mkt Cap
$13.28B
Volume
698,795.00
52W High
$242.00
52W Low
$124.06
PE Ratio
-51.54
ASND Fundamentals
Price
$216.32
Prev Close
$218.10
Open
$217.85
50D MA
$214.51
Beta
0.50
Avg. Volume
685,962.15
EPS (Annual)
-$4.25
P/B
-69.44
$13,224.22
Loading...
Loading...
News
all
press releases
Growth Stocks To Research - February 14th
Prologis, Teledyne Technologies, and Ascendis Pharma A/S are the three Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares in companies expected to...
MarketBeat·7h ago
News Placeholder
More News
News Placeholder
Promising Growth Stocks To Add to Your Watchlist - February 13th
Prologis, Hercules Capital, Ascendis Pharma A/S, Teledyne Technologies, and Hamilton Lane are the five Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are...
MarketBeat·1d ago
News Placeholder
Ascendis Pharma A/S (NASDAQ:ASND) Announces Earnings Results, Misses Estimates By $0.58 EPS
Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report) posted its earnings results on Wednesday. The biotechnology company reported ($0.64) EPS for the quarter, missing analysts' consensus estimates of...
MarketBeat·1d ago
News Placeholder
Ascendis Pharma A/S (NASDAQ:ASND) Given Consensus Rating of "Buy" by Brokerages
Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report) has been assigned a consensus recommendation of "Buy" from the seventeen ratings firms that are presently covering the stock, Marketbeat.com...
MarketBeat·2d ago
News Placeholder
Best Growth Stocks To Research - February 12th
Prologis, Ascendis Pharma A/S, Teledyne Technologies, Tyra Biosciences, Hercules Capital, Hamilton Lane, and Trinity Capital are the seven Growth stocks to watch today, according to MarketBeat's...
MarketBeat·2d ago
News Placeholder
Wedbush Issues Positive Forecast for Ascendis Pharma A/S (NASDAQ:ASND) Stock Price
Wedbush boosted their price target on shares of Ascendis Pharma A/S from $240.00 to $273.00 and gave the company an "outperform" rating in a report on Thursday...
MarketBeat·2d ago
News Placeholder
Ascendis Pharma A/S Q4 Earnings Call Highlights
Ascendis Pharma A/S (NASDAQ:ASND) used its fourth-quarter 2025 earnings call to highlight continued commercial growth for its two marketed rare endocrine disease products, updates across its...
MarketBeat·3d ago
News Placeholder
Growth Stocks To Follow Today - February 11th
Prologis, Teledyne Technologies, Ascendis Pharma A/S, Hamilton Lane, and Tyra Biosciences are the five Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are...
MarketBeat·3d ago
News Placeholder
Growth Stocks To Consider - February 9th
Prologis, Ascendis Pharma A/S, and Teledyne Technologies are the three Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies expected to...
MarketBeat·5d ago
News Placeholder
Promising Growth Stocks To Consider - February 8th
Prologis, Teledyne Technologies, Ascendis Pharma A/S, Hamilton Lane, and Hercules Capital are the five Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are...
MarketBeat·6d ago
<
1
2
...
>

Latest ASND News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.